ADAR has been recently described as a major factor for resistance to immunotherapy and radiotherapy.4 In our model, ADAR gene silencing using siRNA sequences sensitises cancer cells to IFN stimulation in a similar fashion as USP18 does. The gene discussed is IFNA1; the disease is cancer.